Please login to the form below

Not currently logged in


This page shows the latest GAD news and features for those working in and with pharma, biotech and healthcare.

Chasing the cure for Parkinson's disease

Chasing the cure for Parkinson's disease

NLX· P101 uses adeno-associated virus-mediated transfer to introduce the gene for GAD into the brain. ... GAD converts glutamate (ie main excitatory neurotransmitter) into gamma-aminobutyric acid (GABA; main inhibitory neurotransmitter).

Latest news

  • Pfizer uses augmented reflection technology for mental health campaign Pfizer uses augmented reflection technology for mental health campaign

    Pfizer uses augmented reflection technology for mental health campaign. Teams up with Anxiety UK to raise awareness of GAD. ... One of the striking images from Pfizer's video. Pfizer UK has launched a new campaign that uses augmented reflection

  • Diabetes favoured

    GAD 65 antigen based. therapy for type 1 diabetes. Ongoing phase III.

  • An unexpected turn

    Quetiapine was launched for the treatment of schizophrenia and bipolar disorders, and is currently in preregistration for the treatment of depression and generalised anxiety disorder (GAD) in the US, with supplemental ... In another trial, patients with

  • Beating the system

    NLX-P101 uses an adeno-associated virus to carry the glutamic acid decarboxylase (GAD) gene into the neurones of the subthalamic nucleus - the part of the brain that is over-stimulated

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...